ArticlePharmaceuticals (Basel, Switzerland)2025
YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer.
Vicenç Ruiz de Porras, Martin K Bakht, Maria Fernandez-Saorín, Clara Alcon, Luis Palomero, Júlia Francisco-Rodon, Mariona Figols, Joan Montero, Vincenza Conteduca, Himisha Beltran and 1 more
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Vicenç Ruiz de PorrasGRET and Toxicology Unit, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.ORCID 0000-0002-4352-1784 Maria Fernandez-SaorínCARE Program, Germans Trias i Pujol Research Institute (IGTP), Camí de les Escoles, s/n, 08916 Badalona, Spain.
Clara AlconDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, 08007 Barcelona, Spain.
Luis PalomeroDepartment Llenguatges i Sistemes Informàtics, Institute of New Imaging Technologies, Universitat Jaume I, Av. Sos Baynat s/n, 12071 Castellón de la Plana, Spain.ORCID 0000-0002-9144-1017 Júlia Francisco-RodonCARE Program, Germans Trias i Pujol Research Institute (IGTP), Camí de les Escoles, s/n, 08916 Badalona, Spain.
Mariona FigolsMedical Oncology Department, Althaia Xarxa Assistencial Universitària de Manresa, C/Dr. Joan Soler, 1-3, 08243 Manresa, Spain.ORCID 0000-0001-7563-3812 Joan MonteroDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, 08007 Barcelona, Spain.
Vincenza ConteducaUnit of Medical Oncology and Biomolecular Therapy, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.ORCID 0000-0002-6921-714X Himisha BeltranDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Albert FontCARE Program, Germans Trias i Pujol Research Institute (IGTP), Camí de les Escoles, s/n, 08916 Badalona, Spain.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
carboplatinmetastatic castration-resistant prostate cancersurvivinYM155
Identifiers
PMID41304997
PMCPMC12655369
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390